These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2121554)

  • 1. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome.
    Edelstein MC; Seltman HJ; Cox BJ; Robinson SM; Shaw RA; Muasher SJ
    Fertil Steril; 1990 Nov; 54(5):853-7. PubMed ID: 2121554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate.
    Schoolcraft W; Sinton E; Schlenker T; Huynh D; Hamilton F; Meldrum DR
    Fertil Steril; 1991 Mar; 55(3):563-6. PubMed ID: 1900481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins.
    Silverberg KM; Burns WN; Olive DL; Riehl RM; Schenken RS
    J Clin Endocrinol Metab; 1991 Oct; 73(4):797-803. PubMed ID: 1909704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.
    Gonen Y; Balakier H; Powell W; Casper RF
    J Clin Endocrinol Metab; 1990 Oct; 71(4):918-22. PubMed ID: 2119392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study.
    Golbasi H; Ince O; Golbasi C; Ozer M; Demir M; Yilmaz B
    J Obstet Gynaecol; 2019 Feb; 39(2):157-163. PubMed ID: 30280612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in vitro fertilization/embryo transfer outcome.
    Burns WN; Witz CA; Klein NA; Silverberg KM; Schenken RS
    J Assist Reprod Genet; 1994 Jan; 11(1):17-23. PubMed ID: 7949830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed occurrence of an LH surge after HCG administration during ovarian stimulation with gonadotrophins: effect of LHRH treatment.
    Rojas FJ; Moretti-Rojas I; Balmaceda JP; Asch RH
    Hum Reprod; 1989 Aug; 4(6):643-6. PubMed ID: 2506219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.
    Hugues JN; Massé-Laroche E; Reboul-Marty J; Boîko O; Meynant C; Cédrin-Durnerin I
    Fertil Steril; 2011 Sep; 96(3):600-4. PubMed ID: 21880277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with extremely high progesterone concentrations on the day of HCG administration.
    Tsai YR; Lin YJ; Lin YC; Hsu TY; Lan KC
    J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101720. PubMed ID: 32113001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles.
    Givens CR; Schriock ED; Dandekar PV; Martin MC
    Fertil Steril; 1994 Nov; 62(5):1011-7. PubMed ID: 7926111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report.
    Cassidenti DL; Sauer MV; Paulson RJ; Ditkoff EC; Rivier J; Yen SS; Lobo RA
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1806-10. PubMed ID: 1750479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.